Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    63,499.79
    -2,958.05 (-4.45%)
     
  • CMC Crypto 200

    1,351.70
    -30.87 (-2.23%)
     
  • FTSE 100

    8,092.87
    +52.49 (+0.65%)
     
  • Gold

    2,340.80
    +2.40 (+0.10%)
     
  • Crude Oil

    82.89
    +0.08 (+0.10%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Activist investor Trian trims P&G, Mondelez stakes

NEW YORK (Reuters) - Activist investment firm Trian Fund Management LP has trimmed its stake in two consumer staples companies, Procter & Gamble Co and snack foods company Mondelez International Inc, according to regulatory filings.

Trian, founded by Nelson Peltz, Ed Garden and Peter May, held 8.9 million shares in P&G at the end of the first quarter, down 9.6% from the 9.8 million shares it owned at the end of the fourth quarter, according to a regulatory filing.

Peltz joined the P&G board in 2018 after a bitter proxy contest.

The firm also cut its stake in Mondelez by 23% to hold 9.4 million shares.

ADVERTISEMENT

The so-called 13F filings show what fund managers owned at the end of the first quarter and while they are backward-looking, they are closely watched for clues on trends and what stocks certain fund managers are favoring.

New York-based Trian is known for proposing operational fixes at its portfolio companies, often through white papers. The activist firm presents itself as a partner that can offer constructive advice rather than the corporate raider intent on breaking companies apart.

(Reporting by Megan Davies in New York and Svea Herbst-Bayliss in Boston; Editing by Matthew Lewis)